Fast induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors

被引:32
作者
Larregina, AT
Morelli, AE
Dewey, RA
Castro, MG
Fontana, A
Lowenstein, PR
机构
[1] Univ Manchester, Dept Med, Mol Med Unit, Manchester M13 9PT, Lancs, England
[2] Univ Zurich Hosp, Dept Internal Med, Clin Immunol Sect, Zurich, Switzerland
基金
英国惠康基金;
关键词
293; cells; adenoviral vectors; FasL; Fas/Apo-1; apoptosis; immune privilege;
D O I
10.1038/sj.gt.3300615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human embryonic kidney 293 cells contain the E1 region of adenovirus type 5, and thus sustain, through transcomplementation, the production of recombinant E1-deleted adenovirus vectors, During attempts to produce recombinant adenovirus expressing the apoptosis-inducing molecule Fas ligand (FasL) under the control of a very strong truncated major immediate-early human cytomegalovirus (MEhCMV) promoter, we discovered that 293 cells were nor surviving the initial cotransfection with a shuttle plasmid encoding the mouse FasL; and pJM17 a plasmid containing the genome of adenovirus type 5 with deletions in the E1-E3 regions, in an unpackagable form. Investigation of the reason for massive cell death after cotransfection led us to determine that 293 cells express the FasL receptor Fas-Apo1 (CD95), and respond with apoptosis to the cross-linking of Fas-Apo1 with either IgM monoclonal antibodies or FasL. Therefore, we decided to generate adenoviral vectors expressing FasL under the control of tissue-specific and/or -inducible promoter elements. Our findings can explain difficulties several groups have had in generating recombinant adenoviral vectors expressing FasL using 293 cells, as well as the lower titres reported.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 30 条
[1]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[2]  
ARA H, 1997, NAT MED, V3, P843
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]  
EASTMAN A, 1995, CELL DEATH DIFFER, P41
[5]  
Ehl S, 1996, J IMMUNOL, V156, P2357
[6]   ABLATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES TRANSGENE PERSISTENCE AND DECREASES INFLAMMATORY RESPONSE IN MOUSE-LIVER [J].
ENGELHARDT, JF ;
YE, XH ;
DORANZ, B ;
WILSON, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6196-6200
[7]   Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors [J].
Fallaux, FJ ;
Kranenburg, O ;
Cramer, SJ ;
Houweling, A ;
VanOrmondt, H ;
Hoeben, RC ;
vanderEb, AJ .
HUMAN GENE THERAPY, 1996, 7 (02) :215-222
[8]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[9]   Fas-ligand: Privilege and peril [J].
Green, DR ;
Ware, CF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :5986-5990
[10]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192